(Q84117070)

English

Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes

scientific article published on 19 April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Cryptococcus neoformans

1 reference

based on heuristic

inferred from title

Débora de Souza Collares Maia Castelo-Branco

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Rossana de Aguiar Cordeiro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

George Cândido Nogueira

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Raimunda Sâmia Nogueira Brilhante

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Carlos Eduardo Cordeiro Teixeira

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Charles Ielpo Mourão

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Manoel de Araújo Neto Paiva

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Joyce Fonteles Ribeiro

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

André Jalles Monteiro

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

José Júlio Costa Sidrim

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marcos Fábio Gadelha Rocha

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

19 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Veterinary Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

159

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

375-380

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Yeasts from Macrobrachium amazonicum: a focus on antifungal susceptibility and virulence factors of Candida spp

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Tipranavir exhibits different effects on opportunistic pathogenic fungi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

PCR-REA as an important tool for the identification of Cryptococcus neoformans and Cryptococcus gattii from human and veterinary sources.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Protective effects of farnesol against oral candidiasis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Enhanced production of farnesol by Candida albicans treated with four azoles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Do major species concepts support one, two or more species within Cryptococcus neoformans?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Cryptococcosis: update and emergence of Cryptococcus gattii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

The biology of the Cryptococcus neoformans species complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol induces apoptosis and oxidative stress in the fungal pathogen Penicillium expansum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Virulence in Cryptococcus species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Molecular typing of IberoAmerican Cryptococcus neoformans isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Transcriptional response of Candida parapsilosis following exposure to farnesol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Inhibition of Fusarium graminearum growth and development by farnesol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Farnesol-induced apoptosis in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

In vitro antifungal susceptibility of Cryptococcus gattii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2012.04.008

7 January 2021

Identifiers

10.1016/J.VETMIC.2012.04.008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22580194%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84117070&oldid=2117992732"